OMDA Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
87.8M
+12.5%
78.0M
+2.9%
75.8M
+11.5%
68.0M
+10.9%
61.4M
Cost of Revenue
24.0M
-18.1%
29.4M
+32.3%
22.2M
-3.4%
23.0M
+9.0%
21.1M
Gross Profit
63.8M
+31.0%
48.7M
-9.3%
53.7M
+19.1%
45.1M
+11.8%
40.3M
Operating Expenses
60.2M
+12.6%
53.5M
+6.1%
50.4M
+5.9%
47.6M
+6.6%
44.6M
R&D
14.6M
+15.2%
12.7M
+9.9%
11.6M
+12.1%
10.3M
+2.8%
10.0M
SG&A
45.6M
+11.9%
40.8M
+5.0%
38.8M
+4.1%
37.3M
+7.7%
34.6M
Operating Income
3.5M
+174.2%
-4781000
-245.7%
3.3M
+230.6%
-2513000
+42.2%
-4344000
EBITDA
5.1M
+256.7%
-3273000
-169.2%
4.7M
+509.7%
-1154000
+61.4%
-2992000
Net Income
5.3M
+278.2%
-2970000
-157.6%
5.2M
+262.3%
-3178000
+40.2%
-5311000
EPS (Basic)
$0.09
+280.0%
$-0.05
-155.6%
$0.09
+250.0%
$-0.06
+75.0%
$-0.24
EPS (Diluted)
$0.08
+260.0%
$-0.05
-155.6%
$0.09
+250.0%
$-0.06
+75.0%
$-0.24
Shares (Diluted)
63.9M
+8.5%
58.9M
+0.4%
58.7M
+1.8%
57.7M
+162.4%
22.0M
Omada Health (OMDA) โ€” Financials